dr. joshua richter discusses multiple myeloma clinical trials
Published 7 years ago • 221 plays • Length 2:01
Download video MP4
Download video MP3
Similar videos
-
21:02
emerging bispecifics myeloma patients should know about | dr. joshua richter | the patient story
-
5:20
what are bispecifics in multiple myeloma? (for patients and caregivers) | dr. joshua richter
-
1:52
dr. noa biran discusses multiple myeloma clinical trials
-
3:04
what are celmods in multiple myeloma (& when will they be available?) | dr. joshua richter
-
5:02
questions to ask my doctor about new myeloma treatments | dr. joshua richter | the patient story
-
6:18
what to expect with car t cell therapy and bispecifics in myeloma (2022) | dr. joshua richter
-
1:07:46
healthtree podcast for myeloma: joshua richter, md, mount sinai covid update
-
1:08
dr joshua richter discusses patient financial burden of new treatments and cures
-
10:30
fighting multiple myeloma with triplet therapy
-
2:31
asco/eha 2024 myeloma highlights- imroz, dreamm-7, dreamm-8 | joshua richter, md | eha 2024
-
1:09:47
myeloma crowd: david chung, md, phd, memorial sloan kettering cancer center
-
3:11
bispecific antibodies | joshua richter, md | ash 2022
-
1:01
dr. richter discusses the administration of carfilzomib
-
1:03
dr. richter on toxicities of treatments for multiple myeloma
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
-
2:18
t cell re-direction therapy | joshua richter, md | eha 2022
-
58:19
sequencing bcma myeloma therapies
-
1:54
dr. richter on findings of a study on symptom management in multiple myeloma
-
1:58
an expert’s take on promising myeloma treatment and research
-
1:38
bridging patients with myeloma to subsequent treatments with chemotherapy & stem cell support
-
5:08
joshua richter, md, talks results from linker-mm1 study
-
1:56
myeloma treatment: when should a clinical trial be considered?
Clip.africa.com - Privacy-policy